Thursday, June 8, 2017
- 1:15pm-2:45pm
-
How will new technology change deep brain stimulation programming?
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- 1:15pm-2:45pm
-
Hypertension and Parkinson’s disease
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- 1:15pm-2:45pm
-
Hypometabolism in Orbitofrontal and Perirhinal Cortex is Associated with Impulse Control Disorder in Parkinson´s Disease
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- 1:15pm-2:45pm
-
Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC): a Mexican case report.
Pediatric Movement Disorders · Exhibit Hall C
- 1:15pm-2:45pm
-
Identification of the optimal carbidopa concentration in subcutaneously administered ND0612
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- 1:15pm-2:45pm
-
Immunomodulatory therapy in stiff-person syndrome (SPS): a controlled Rituximab-randomised study
Other · Exhibit Hall C
- 1:15pm-2:45pm
-
Impact of injection interval on patient satisfaction in the routine treatment of cervical dystonia with abobotulinumtoxinA
Dystonia · Exhibit Hall C
- 1:15pm-2:45pm
-
Impacts of White Matter Hyperintensities on Limit of Stability in Drug-naïve, de novo Patients with Idiopathic Parkinson’s Disease
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- 1:15pm-2:45pm
-
Impaired Pain Processing in Functional Dystonia
Dystonia · Exhibit Hall C
- 1:15pm-2:45pm
-
Impaired sensorimotor and visual networks in drug naive Parkinson’s disease based on graph theoretical analysis
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- «Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 41
- Next Page»